Abstract:The 3T3-L1 adipocyte differentiation system is a reliable in vitro model for adipogenesis in vivo. Under the controlled conditions of cell culture, 3T3-L1 preadipocytes can be induced (with appropriate hormonal agents) to differentiate into cells that have the biochemical and morphological characteristics of tissue adipocytes. We have identified, cloned, and characterized a number of adipocyte genes that are coordinately activated during differentiation and contribute to acquisition of the adipocyte phenotype. C/EBPα serves as a pleiotropic transcriptional activator of these and many other adipocyte genes. Expression of C/EBPα is not only required for, but is sufficient (in combination with PPARγ) to activate the differentiation program of 3T3-L1 preadipocytes without the use of hormonal agents. In view of the importance of C/EBPα in adipocyte differentiation, we have begun to characterize the promoter of the C/EBPα gene. In addition to a C/EBP regulatory element in the proximal promoter of the gene, we have identified three repressor binding sites. A differentially expressed nuclear factor that binds to two of these sites has been isolated and characterized. This factor, referred to as CUP (C/EBPα Undifferentiated Protein), is expressed by preadipocytes but not adipocytes. Both the mouse and human C/EBPα genes possess two CUP binding sites, one in the 5′-flanking and another in the 5′-untranslated region of the genes. Mutation of either CUP site individually has little effect on reporter gene transcription mediated by the promoter; however, when both CUP sites are mutated marked synergistic “derepression” occurs. We have purified CUP from 3T3-L1 preadipocytes and shown it to be an isoform of the transcription factor AP-2α. Forced expression of the AP-2α1 isoform in adipocytes, which normally do not express this factor, inhibits reporter gene transcription mediated by the C/EBPα promoter. Our findings indicate that CUP/AP-2α is a repressor of the C/EBPα gene promoter and suggest that this factor maintains the gene in a repressed state prior to differentiation. A binding site (a GC box) for another repressor has been identified at the 5′-end of the C/EBP regulatory element in the C/EBPα promoter. The transcription factor Sp1, which is expressed by preadipocytes, was found to bind at this site. By binding at this site, Sp1 sterically can block access to the C/EBP binding site by members of the C/EBP family. Thus, transcriptional activation of the C/EBPα a gene by C/EBPβ (and possibly C/EBPδ), which is thought to occur early in the adipocyte differentiation program, would be prevented. Consistent with this view, transactivation of C/EBPα promoter by C/EBPβ is inhibited by Sp1. Preliminary evidence indicates that the differentiation inducers increase the rate of turnover of Sp1. Lowering the Sp1 level early in the differentiation program would facilitate binding of C/EBPβ to the C/EBP regulatory element and, thereby, transcriptional activation of the C/EBPα gene.

Transcriptional and translational regulation of CCAAT/Enhancer Binding Protein β expression by P53

Transcriptional Regulation of Pp2a-A Alpha is Mediated by Multiple Factors Including Ap-2 Alpha, Creb, Ets-1, and Sp-1

Transcription Factor C/EBPβ and 17Β-Estradiol Promote Transcription of the Porcine P53 Gene

The tumor suppressor p53 regulates autophagosomal and lysosomal biogenesis in lung cancer cells by targeting transcription factor EB.

Progress of Transcription Factor CCAAT Enhancer Binding Protein Β

Single-cell Transcriptomic Profiling of Non-Hematopoietic Circulating Cells in Mid-Gestational Mouse Embryos.

Transcriptional Regulation of Estrogen Receptor-Alpha by P53 in Human Breast Cancer Cells

BAC transgenic mice provide evidence that p53 expression is highly regulated in vivo

Repression of Transcription Mediated by Dual Elements in the CCAAT/enhancer Binding Protein Α Gene

Locally acting transcription factors regulate p53-dependent cis-regulatory element activity

Transcriptional Regulation of Adipocyte Differentiation: A Central Role for CCAAT/Enhancer-binding Protein (C/EBP) β

p53 exerts anticancer effects by regulating enhancer formation and activity

P53 Represses Transcription of Ring Finger Lim Domain-Binding Protein Rlim Through Sp1

Post-translational Modification of Transcription Factor C/EBPβ

The effect of the transcriptional regulation of p53 on RhoE gene

The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation

The Adipocyte Differentiation Program: RepressiodDerepression of the C/EBPα Gene

PPARγ forms a bridge between DNA methylation and histone acetylation at the C/EBPα gene promoter to regulate the balance between osteogenesis and adipogenesis of bone marrow stromal cells.

Preferential translation of p53 target genes

P53 Functions As a Negative Regulator of Osteoblastogenesis, Osteoblast-Dependent Osteoclastogenesis, and Bone Remodeling

Ap-2 Beta Enhances P53-Mediated Transcription Of The Alpha B-Crystallin Gene Through Stabilizing P53